Pressmeddelande

BioStock: Chronic pain in focus for CombiGene´s new collaboration

Cision Publicerad: 11 Jan 2023 11:07

CombiGene has entered into a collaboration agreement with Danish Zyneyro regarding the continued development of treatments for chronic pain conditions – a peptide with short-term benefits and a gene therapy with potentially lifelong effects. To find out more about what sparked CombiGene’s interest in Zyneyro and their projects in temporary and chronic pain conditions, BioStock contacted CombiGene’s CEO Jan Nilsson.

Read the full interview with CombiGene's CEO Jan Nilsson at biostock.se:

https://www.biostock.se/en/2023/01/chronic-pain-in-focus-for-combigenes-new-collaboration/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Nyheter om CombiGene

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!